Related Experiment Video
Updated: Mar 22, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite
Marc Poirot1, Sandrine Silvente-Poirot1
1Sterol Metabolism and Therapeutic Innovations, Cancer Research Center of Toulouse, INSERM UMR 1037, University of Toulouse, F-31037 Toulouse, France Institut Claudius Regaud, Institut Universitaire du Cancer, F-31059 Toulouse, France marc.poirot@inserm.fr sandrine.poirot@inserm.fr.
Abstract:
Dendrogenin A (DDA) is the first steroidal alkaloid (SA) to be identified in human tissues to date and arises from the stereoselective enzymatic conjugation of 5,6α-epoxycholesterol (5,6α-EC) with histamine (HA). DDA induces the re-differentiation of cancer cellsin vitroandin vivoand prevents breast cancer (BC) and melanoma development in mice, evidencing its protective role against oncogenesis. In addition, DDA production is lower in BCs compared with normal tissues, suggesting a deregulation of its biosynthesis during carcinogenesis. The discovery of DDA reveals the existence of a new metabolic pathway in mammals which lies at the crossroads of cholesterol and HA metabolism and which leads to the production of this metabolic tumour suppressor.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Abnormal Proliferation
Cholinesterases: Distribution and Function
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...

